Fig. 2From: The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situImaging features of DCIS on final surgical pathology. Axial fat-suppressed T1-weighted contrast-enhanced MRI revealed a small oval-shaped mass with homogeneous enhancement (left). MRI with a CAD color overlay map revealed the tumor size and enhancement kinetics, i.e., a 102% peak enhancement and a 100% persistent component (right)Back to article page